Minerals Technologies
MTX
65.11
-0.87
-1.32%
Minerals Technologies
US · MTX
#2758 by market cap
Listed 1970
65.11
-0.87
-1.32%
Live - 5344 symbols - heartbeat 450s ago
· 2026-10-07 19:54
After-hours
65.11
0.00%
- Market cap
- 2.03B
- P/E (TTM)i
- -29.33
- P/Bi
- 1.31
- EPSi
- -0.59
- Div yieldi
- 0.72%
- 52W posi
- 38%
Reader sentiment
Are you bullish or bearish on MTX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.79, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.17% YoY
Margins
- Gross margin
- 24.99%
- Operating margin
- 13.85%
- Net margin
- -0.89%
Key ratios & quality
- Enterprise valuei
- 2.66B
- Altman Z-Scorei
- 2.79
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.81B | 1.79B | 1.59B | 1.86B | 2.13B | 2.17B | 2.12B | 2.07B |
| Gross profit | 461.40M | 440.60M | 405.40M | 446.50M | 465.00M | 507.10M | 547.70M | 518.00M |
| Selling & admin expenses | 178.60M | 187.50M | 176.50M | 186.20M | 192.10M | 206.00M | 209.20M | 208.00M |
| Research & development | 22.70M | 20.30M | 19.90M | 19.50M | 20.40M | 21.20M | 23.00M | 22.90M |
| Operating profit | 260.10M | 232.80M | 209.00M | 240.80M | 252.50M | 279.90M | 315.50M | 287.10M |
| Pretax profit | 204.10M | 157.30M | 138.00M | 202.30M | 156.70M | 107.70M | 223.60M | -14.00M |
| Tax | 34.40M | 22.80M | 24.40M | 36.60M | 32.10M | 23.70M | 59.40M | 4.90M |
| Net profit | 173.20M | 136.40M | 115.80M | 168.50M | 126.30M | 88.30M | 170.90M | -14.00M |
| Basic EPS | 5 | 4 | 3 | 5 | 4 | 3 | 5 | -1 |
| Diluted EPS | 4.75 | 3.78 | 3.29 | 4.86 | 3.73 | 2.58 | 5.17 | -0.59 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 491.80M | 528.90M | 532.40M | 519.50M | 546.90M | 548.40M |
| Gross profit | 119.60M | 136.90M | 137.00M | 124.50M | 131.10M | 133.80M |
| Selling & admin expenses | 50.60M | 52.20M | 53.00M | 52.20M | 57.50M | 53.30M |
| Research & development | 5.80M | 5.70M | 5.60M | 5.80M | 6.10M | 5.90M |
| Operating profit | 63.20M | 79.00M | 78.40M | 66.50M | 67.50M | 74.60M |
| Pretax profit | -176.30M | 59.10M | 56.60M | 46.60M | 45.90M | -231.30M |
| Tax | -32.10M | 13.90M | 13.50M | 9.60M | 9.90M | -46.20M |
| Net profit | -143.00M | 46.30M | 44.20M | 38.50M | 37.30M | -182.60M |
| Basic EPS | -5 | 1 | 1 | 1 | 1 | -6 |
| Diluted EPS | -4.51 | 1.44 | 1.37 | 1.19 | 1.17 | -5.90 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 876.30M | 919.20M | 1.03B | 1.03B | 1.07B | 1.10B | 1.13B | 1.16B |
| Cash & ST investments | 212.60M | 243.20M | 371.80M | 304.40M | 252.80M | 321.50M | 337.10M | 332.60M |
| Inventory | 239.20M | 253.30M | 248.20M | 297.70M | 348.80M | 325.40M | 342.10M | 350.20M |
| Total assets | 3.09B | 3.11B | 3.21B | 3.37B | 3.40B | 3.35B | 3.39B | 3.47B |
| Total current liabilities | 381.90M | 398.50M | 295.80M | 419.80M | 502.60M | 457.30M | 397.70M | 555.40M |
| Short-term debt | 108.50M | 103.30M | 1.00M | 80.80M | 134.20M | 103.40M | 11.60M | 6.70M |
| Long-term debt | 907.80M | 824.30M | 933.20M | 936.20M | 928.10M | 911.10M | 959.60M | 955.00M |
| Total liabilities | 1,701,800,000.00 | 1,678,000,000.00 | 1,710,700,000.00 | 1,794,700,000.00 | 1,788,400,000.00 | 1,659,900,000.00 | 1,610,700,000.00 | 1,719,300,000.00 |
| Total equity | 1.39B | 1.43B | 1.50B | 1.58B | 1.61B | 1.69B | 1.78B | 1.75B |
| Retained earnings | 1.77B | 1.91B | 2.01B | 2.17B | 2.28B | 2.36B | 2.51B | 2.48B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 1.14B | 1.17B | 1.17B | 1.16B | 1.16B | 1.18B |
| Cash & ST investments | 312.20M | 319.90M | 328.30M | 332.60M | 321.30M | 346.20M |
| Inventory | 352.50M | 359.60M | 363.70M | 350.20M | 357.90M | 355.60M |
| Total assets | 3.40B | 3.45B | 3.46B | 3.47B | 3.47B | 3.50B |
| Total current liabilities | 599.90M | 602.80M | 591.50M | 555.40M | 543.40M | 828.50M |
| Short-term debt | 26.30M | 24.30M | 19.90M | 6.70M | 12.20M | 12.00M |
| Long-term debt | 960.10M | 959.00M | 957.80M | 955.00M | 954.00M | 952.90M |
| Total liabilities | 1,766,400,000.00 | 1,766,800,000.00 | 1,749,300,000.00 | 1,719,300,000.00 | 1,703,800,000.00 | 1,918,400,000.00 |
| Total equity | 1.63B | 1.69B | 1.71B | 1.75B | 1.76B | 1.58B |
| Retained earnings | 2.37B | 2.41B | 2.45B | 2.48B | 2.51B | 2.33B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 203.60M | 238.30M | 240.60M | 232.40M | 105.70M | 233.60M | 236.40M | 193.70M |
| Depreciation & amortization | 94.30M | 98.40M | 93.90M | 94.60M | 94.20M | 95.00M | 94.90M | 91.20M |
| Free cash flow | 127.70M | 173.30M | 173.80M | 146.40M | 23.40M | 140.10M | 146.90M | 86.60M |
| Dividends paid | -7.10M | -7.00M | -6.80M | -6.80M | -6.50M | -8.10M | -13.20M | -14.20M |
| Stock buybacks / issuance | -21.70M | -41.00M | -40.70M | -74.70M | -56.00M | -14.20M | -63.60M | -58.50M |
| Ending cash balance | 208.80M | 241.60M | 367.70M | 299.50M | 247.20M | 317.20M | 333.10M | 329.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -4.40M | 62.90M | 70.90M | 64.30M | 32.10M | 63.00M |
| Depreciation & amortization | 23.50M | 22.00M | 22.40M | 23.30M | 24.90M | 23.50M |
| Free cash flow | -22.70M | 33.80M | 43.60M | 31.90M | 9.00M | 35.80M |
| Dividends paid | -3.60M | -- | -- | -3.80M | -3.70M | -- |
| Stock buybacks / issuance | -11.50M | -- | -- | -11.00M | -5.40M | -- |
| Ending cash balance | 306.60M | 313.80M | 319.60M | 329.00M | 315.90M | 342.20M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.97 | 9.63 | 7.85 | 10.96 | 7.84 | 5.21 | 9.83 | -1.06 |
| ROA %i | 5.58 | 4.28 | 3.56 | 4.99 | 3.61 | 2.49 | 4.96 | -0.54 |
| ROIC %i | 9.02 | 7.22 | 6.09 | 7.87 | 6.04 | 4.91 | 7.74 | 0.82 |
| 5-year avg ROE %i | 13.43 | 13.19 | 12.33 | 11.74 | 9.85 | 8.30 | 8.34 | 6.55 |
| EBIT margin %i | 13.83 | 11.19 | 11.05 | 12.89 | 9.44 | 7.69 | 13.22 | 1.95 |
| FCF / sales %i | 7.06 | 9.68 | 10.90 | 7.88 | 1.10 | 6.46 | 6.93 | 4.18 |
| Current ratioi | 2.29 | 2.31 | 3.49 | 2.45 | 2.13 | 2.40 | 2.84 | 2.08 |
| Quick ratioi | 1.57 | 1.55 | 2.50 | 1.60 | 1.31 | 1.58 | 1.82 | 1.32 |
| Debt / assetsi | 32.92 | 29.80 | 29.11 | 30.14 | 31.23 | 30.31 | 28.62 | 27.72 |
| LT debt / equityi | 67.07 | 58.77 | 63.88 | 60.82 | 58.76 | 55.15 | 54.93 | 55.74 |
| Interest coveragei | 5.45 | 4.64 | 4.61 | 6.44 | 4.57 | 2.82 | 4.96 | 0.74 |
| Revenue CAGR (3Y) %i | 0.19 | 3.02 | -1.64 | 0.93 | 5.87 | 10.81 | 4.47 | -0.84 |
| Net income CAGR (3Y) %i | 16.13 | -0.18 | -16.79 | -0.92 | -2.71 | -9.22 | 0.54 | -- |
| FCF CAGR (3Y) %i | -11.46 | 2.13 | 9.91 | 4.66 | -48.70 | -6.93 | 0.11 | 54.68 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -1.45 | 0.13 | -0.09 | -1.06 | 9.73 | -4.20 |
| ROA %i | -0.70 | 0.06 | -0.05 | -0.54 | 4.71 | -1.93 |
| ROIC %i | 0.68 | 1.61 | 1.45 | 0.82 | 7.70 | -0.91 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.07 | 3.20 | 3.04 | 1.95 | 12.30 | -1.40 |
| FCF / sales %i | 4.09 | 4.30 | 4.68 | 4.18 | 5.56 | 5.60 |
| Current ratioi | 1.89 | 1.95 | 1.98 | 2.08 | 2.13 | 1.43 |
| Quick ratioi | 1.20 | 1.24 | 1.25 | 1.32 | 1.35 | 0.92 |
| Debt / assetsi | 29.00 | 28.46 | 28.27 | 27.72 | 27.88 | 27.61 |
| LT debt / equityi | 60.07 | 57.98 | 57.18 | 55.74 | 55.21 | 61.68 |
| Interest coveragei | 0.77 | 1.22 | 1.16 | 0.74 | 4.88 | -0.58 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Consumer & Specialties is the largest reported line at 50.05% of revenue, across 2 reported segments.
- Engineered Solutions follows at 49.95%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Consumer & Specialties50.05%
Engineered Solutions49.95%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.